Stephen M. Sammut
Founder & President, Pangea University for the Health Sciences
Steve has founded, managed or financed over 40 companies in life sciences and IT globally. He is Chairman of the Advisory Board of Alta Semper, a private equity fund focused on African healthcare. Over the last several decades he has been a partner or adviser to numerous health care-oriented venture capital and private equity firms internationally and has also founded health care management MBA programs in India and throughout Africa.
Steve was a Venture Partner at Burrill & Company, a biotechnology and health care venture fund, until 2008. He has consulted for the IFC/World Bank on PE/VC, technology transfer and program assessment, and investments in Fintech for economic development. Similarly, he has advised the governments of Brazil, China, India, Japan, Malaysia, Singapore, South Korea and Taiwan in the development of policies to promote venture financing of their biotechnology industries.
Earlier in his career he was VP, SR One, the venture capital arm of GSK, and VP for Development and Private Equity at Teleflex Incorporated. He has also been Managing Director of Technology Transfer at the University of Pennsylvania and Thomas Jefferson University. He began his career as co-founder and CEO of the Philadelphia transplant organ bank, known today as the Gift of Life Donor Program.
Steve is also Senior Fellow, Health Care Management and Lecturer, Entrepreneurship at the Wharton School. During his 25 years teaching at Wharton and other business schools in India, Israel, Kenya, Portugal and Russia, he has created over a dozen courses that he has taught to nearly 11,000 students. These courses include: Venture Capital; Private Equity in Emerging Markets; Strategic Management of Intellectual Property; Health Care Entrepreneurship; and, the Role of the Private Sector in Global Health among others. His research focuses on international development and health care and biotechnology capacity development in emerging economies, as well as business model innovation in biotechnology. He has published articles in Nature Biotechnology, the New England Journal of Medicine, the Journal of Commercial Biotechnology and has authored numerous book chapters on health care and biotechnology. Steve puts the findings of his research into practice through the International Institute for Biotechnology Entrepreneurship, an organization which he founded and manages, that has offered over 50 intensive training programs in 14 countries to over 2000 entrepreneurs.
He is visiting faculty and served as coordinator of the Indian School of Business healthcare program and is visiting faculty at the Strathmore Business School in Nairobi where he founded the first Healthcare Management MBA program on the African continent, as well as founding the African Institute for Healthcare Management, an organization focused on developing faculty and teaching materials to advance health services. He is currently developing a School of Global Public Health at Strathmore University.
His board memberships have included HealthRight International, Center for Medicine in the Public Interest, BioEthics International, Pandorum Technologies, the Africa Health Fund, Alta Semper, the Russian Foundation for Cancer Research and numerous other profit and non-profit organizations in the US and the emerging markets.
He holds graduate and undergraduate degrees from Villanova University, an MBA from the Wharton School of the University of Pennsylvania and engaged in special studies in medicine and epidemiology at Hahnemann Medical college for two years. He is a doctoral candidate at the Fox School of Business at Temple University where he is researching the implementation of precision medicine in emerging economies.